Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP Implementation of Mothers in Antenatal Care
PACTR202006650810423Phase 4Unknown
- Sponsor
- National Institutes of Health
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV) (2 arms), sponsored by National Institutes of Health. Primary endpoint: Maternal HIV Incidence. Status: unknown.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202006650810423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202006650810423.